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Cellular transplantation of nephrons. Embryonic renal cellu-
lar primordia transplanted into animal hosts undergo nephro-
genesis in situ, become vascularized by blood vessels of host
origin, exhibit excretory function, and support life in oth-
erwise anephric hosts. Renal primordia can be transplanted
across isogeneic, allogeneic, and both concordant (rat to
mouse) and highly disparate (pig to rodent) xenogeneic bar-
riers. Here I review studies exploring the therapeutic potential
for renal organogenesis posttransplantation of cellular kidney
primordia.
The applicability of kidney allotransplantation to treat
end-stage renal disease (ESRD) is limited by the num-
ber of available organs. In that humans and pigs are of
comparable size, share a similar renal physiology, and be-
cause pigs are plentiful and can be bred to be pathogen
free, it has been proposed that pigs represent an ideal
substitute donor. Unfortunately, the transplantation of
whole vascularized organs such as the kidney from pigs
into the group of primates that includes humans, the great
apes, and old-world monkeys, is rendered problematic
because of the processes of humoral rejection (hypera-
cute and acute vascular rejection) that occur across this
xenogeneic barrier [1–3]. In contrast to xenotransplanta-
tion of whole vascularized organs from pig to primates,
cell and tissue grafts might be feasible, since they are less
susceptible to humoral rejection [4].
Cellular transplantation has limitations. It is difficult
to imagine how functions of structurally complex organs
(glomerular filtration and reabsoption in kidneys) can be
recapitulated by cellular transplants. One potential ap-
proach to replacing such functions is via organogenesis
[3] or growing whole kidneys in situ posttransplantation
of renal metanephric [5] primordia. In that its blood sup-
ply originates from outside the developing organ [6, 7],
the kidney is chimeric. Its ability to attract its own vascu-
lature in situ establishes the potential for a transplanted
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renal primordium to attract a vasculature from a suitable
vascular bed.
The literature provides four reasons why transplanta-
tion of renal primordia to achieve organogenesis in situ,
might be advantageous relative to transplantation of de-
veloped kidneys. First, if developing renal primordia are
obtained at sufficiently early stage, antigen-presenting
cells (APCs) that mediate “direct” host recognition of
alloantigen or xenoantigen would be expected to be ab-
sent because they would not have yet developed in the
donor and migrated into the developing kidney [8–10].
Second, donor antigens such as major histocompatability
complex (MHC) class I and II may not be expressed on
developing promordia to the extent they are expressed
in adult kidney [11, 12]. Third, the immune response to
transplanted fetal tissue differs from that to adult tissue
in terms of the elicitation of a T-helper 2–biased response
when that target organ is of fetal origin [13]. Finally, to the
extent that the renal vasculature originates from outside
the kidney, one would expect a transplanted renal pri-
mordium to be supplied by blood vessels of host origin
[14, 15].
In contrast to the case for rat renal primordia trans-
planted beneath the renal capsule [16, 17], primordia
transplanted into a host rat’s fold of omentum undergo
differentiation and growth in hosts that is not confined by
a tight organ capsule [17]. In contrast to transplanted de-
veloped kidneys that undergo acute rejection [17], embry-
onic day (E) E15 rat primordia (Fig. 1A) transplanted into
nonimmunosuppressed hosts have a normal kidney struc-
ture [18, 19] and ultrastructure [18] postdevelopment in
situ and become vascularized via arteries that originate
from the superior mesenteric artery (SMA) of hosts [18]
and veins that drain into the omentum (Fig. 1B).
Developed renal primordia transplanted onto the
omentum clear inulin infused into the host’s circula-
tion following ureteroureterostomy (Fig. 1C) between
transplant and host [17]. If incubated with the appro-
priate growth factor mix prior to implantation, clear-
ance is enhanced and developed primordia secrete a
concentrated urine [urine volume (UV)/glomerular fil-
tration rate (GFR) <1] [18]. Life can be prolonged in
otherwise anephric rat hosts by prior transplantation and
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Fig. 1. Photomicrograph (A) and photographs (B and C) of rat renal
metanephric primordia. (A) Hematoxylin and eosin–stained section of
an embryonic day (E) E15 rat renal primordium. Abbreviations are: s,
stroma; u, ureter. (B and C) Developed primordium or metanephros
(m) posttransplantation. Abbreviations are: a, artery; v, vein. Arrow
delineates ureteroureterostomy. Magnifications are shown for (A) and
for (B and C) [in (B)] (reproduced with permission [19]).
ureteroureterostomy of a single renal primordium [19].
Survival as a function of time postremoval of all native re-
nal mass (all renal function from the implant) is shown in
Figure 2. Control rats (no transplanted renal primordia)
lived 67 ± 2.7 hours (range 48 to 78 hours) postremoval
of all native host renal mass. Rats in the group with trans-
planted primordium, but with the ureterouretersostomy
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Fig. 2. Survival of rats as a function of time post removal of both kid-
neys. Control rats (N = 13) had no transplanted renal primordia. Rats
in the TX group (N = 4) had a transplanted renal primordium, but
with the ureterouretersostomy severed such that urine was discharged
into the peritoneal cavity. Rats in the TX-EXCR group (N = 5) had a
transplanted renal primordium with an intact uteretoureterostomy that
permitted excretion of urine (reproduced with permission [19]).
severed such that urine was discharged into the peritoneal
cavity lived 65 ± 6.0 hours (range 55 to 76 hours), no
longer than controls. Rats in the group with transplanted
primordium with intact uteretoureterostomy that permit-
ted excretion of urine lived 125 ± 12 hours (range 108 to
170 hours), significantly longer than control or rats with
transplanted primordium, but with the ureterouretersos-
tomy severed such that urine was discharged into the peri-
toneal cavity [19].
Transplantation of renal primordia from E28 outbred
pigs to adult outbred pigs can be carried out without
host immunosuppression [20]. Primordia can be trans-
planted across concordant (rat to mouse) [14] and highly
disparate (pig to rodent) [15, 20] xenogeneic barriers in
costimulatory blocked hosts.
At the present time, the means by which kidney func-
tion can be replaced in humans include dialysis and renal
allotransplantation. Dialytic therapies are lifesaving, but
often poorly tolerated. The success of organ transplanta-
tion is such that the major problem facing the field today
is neither the technical hurdles nor the medical complica-
tions, but rather the shortage of available organs. The use
of pigs in lieu of human subjects as donors (xenotrans-
plantation) is a potential solution for the organ shortage.
For reasons delineated above, cellular grafts from pig to
primate might be feasible, but not for replacing complex
renal functions. In contrast, organogenesis can be accom-
plished for kidney via transplantation of renal primordia.
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